caa a22 4500 445315814 CHVBK 20180317142646.0 cr unu---uuuuu 170323e20110801xx s 000 0 eng 10.1007/s10552-011-9791-y doi (NATIONALLICENCE)springer-10.1007/s10552-011-9791-y Estimation of cancer cases and deaths attributable to infection in China [Elektronische Daten] [Wang Xiang, Ju-Fang Shi, Ping Li, Jian-Bing Wang, Li-Na Xu, Wen-Qiang Wei, Fang-Hui Zhao, You-Lin Qiao, Paolo Boffetta] Background: The burden of cancer attributable to infection in China has not been systematically quantified in detail. Methods: Using the findings of systematic review of prevalence of infectious agents and their relative risks (RRs) of specific cancers, a standard approach was applied to estimate the population proportions of cancers attributed to specific infectious agents in China (attributable fractions, AFs). Together with information from the latest national mortality survey and cancer registries in China, the overall and detailed numbers of cancer cases and deaths caused by infection were estimated. Results: A total of 668,763 cancer cases and 526,567 cancer deaths were attributed to infections in China in 2005, which accounted for 25.9 and 29.4% of the overall cancer cases and deaths of the local population, respectively. More infection-related cancers in men (of~30%) were found compared to that in women (of 25.3% cases and 21.8% deaths). Conclusions: Infectious agents contributed more than one-quarter of the overall cancer number among population in China; further persistently effective vaccination and screening interventions and other preventive efforts against relevant infections should be initiated and strengthened. Springer Science+Business Media B.V., 2011 Cancer nationallicence Infection nationallicence Attributable fraction nationallicence China nationallicence Xiang Wang Department of Cancer Epidemiology, Cancer Institute, Chinese Academy of Medical Sciences, 17 South Panjiayuan Lane, 100021, Beijing, People's Republic of China aut Shi Ju-Fang Department of Cancer Epidemiology, Cancer Institute, Chinese Academy of Medical Sciences, 17 South Panjiayuan Lane, 100021, Beijing, People's Republic of China aut Li Ping Department of Cancer Epidemiology, Cancer Institute, Chinese Academy of Medical Sciences, 17 South Panjiayuan Lane, 100021, Beijing, People's Republic of China aut Wang Jian-Bing Department of Cancer Epidemiology, Cancer Institute, Chinese Academy of Medical Sciences, 17 South Panjiayuan Lane, 100021, Beijing, People's Republic of China aut Xu Li-Na Department of Cancer Epidemiology, Cancer Institute, Chinese Academy of Medical Sciences, 17 South Panjiayuan Lane, 100021, Beijing, People's Republic of China aut Wei Wen-Qiang Department of Cancer Epidemiology, Cancer Institute, Chinese Academy of Medical Sciences, 17 South Panjiayuan Lane, 100021, Beijing, People's Republic of China aut Zhao Fang-Hui Department of Cancer Epidemiology, Cancer Institute, Chinese Academy of Medical Sciences, 17 South Panjiayuan Lane, 100021, Beijing, People's Republic of China aut Qiao You-Lin Department of Cancer Epidemiology, Cancer Institute, Chinese Academy of Medical Sciences, 17 South Panjiayuan Lane, 100021, Beijing, People's Republic of China aut Boffetta Paolo International Prevention Research Institute, 95 Cours Lafayette, 69006, Lyon, France aut Cancer Causes & Control Springer Netherlands 22/8(2011-08-01), 1153-1161 0957-5243 22:8<1153 2011 22 10552 https://doi.org/10.1007/s10552-011-9791-y text/html Onlinezugriff via DOI 1 research-article jats NATIONALLICENCE 856 40 https://doi.org/10.1007/s10552-011-9791-y text/html Onlinezugriff via DOI NATIONALLICENCE 700 1- Xiang Wang Department of Cancer Epidemiology, Cancer Institute, Chinese Academy of Medical Sciences, 17 South Panjiayuan Lane, 100021, Beijing, People's Republic of China aut NATIONALLICENCE 700 1- Shi Ju-Fang Department of Cancer Epidemiology, Cancer Institute, Chinese Academy of Medical Sciences, 17 South Panjiayuan Lane, 100021, Beijing, People's Republic of China aut NATIONALLICENCE 700 1- Li Ping Department of Cancer Epidemiology, Cancer Institute, Chinese Academy of Medical Sciences, 17 South Panjiayuan Lane, 100021, Beijing, People's Republic of China aut NATIONALLICENCE 700 1- Wang Jian-Bing Department of Cancer Epidemiology, Cancer Institute, Chinese Academy of Medical Sciences, 17 South Panjiayuan Lane, 100021, Beijing, People's Republic of China aut NATIONALLICENCE 700 1- Xu Li-Na Department of Cancer Epidemiology, Cancer Institute, Chinese Academy of Medical Sciences, 17 South Panjiayuan Lane, 100021, Beijing, People's Republic of China aut NATIONALLICENCE 700 1- Wei Wen-Qiang Department of Cancer Epidemiology, Cancer Institute, Chinese Academy of Medical Sciences, 17 South Panjiayuan Lane, 100021, Beijing, People's Republic of China aut NATIONALLICENCE 700 1- Zhao Fang-Hui Department of Cancer Epidemiology, Cancer Institute, Chinese Academy of Medical Sciences, 17 South Panjiayuan Lane, 100021, Beijing, People's Republic of China aut NATIONALLICENCE 700 1- Qiao You-Lin Department of Cancer Epidemiology, Cancer Institute, Chinese Academy of Medical Sciences, 17 South Panjiayuan Lane, 100021, Beijing, People's Republic of China aut NATIONALLICENCE 700 1- Boffetta Paolo International Prevention Research Institute, 95 Cours Lafayette, 69006, Lyon, France aut NATIONALLICENCE 773 0- Cancer Causes & Control Springer Netherlands 22/8(2011-08-01), 1153-1161 0957-5243 22:8<1153 2011 22 10552 Metadata rights reserved Springer special CC-BY-NC licence nationallicence BK010053 XK010053 XK010000 NATIONALLICENCE NATIONALLICENCE NL-springer